Stay updated on Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T03:00:14.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.0 released, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-22T05:32:14.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    - Page version updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:16:55.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, a minor update that does not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:04:05.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new site revision label appears: Revision: v3.4.1 replaces Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-07T00:47:25.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Additions include UI labels Show glossary and Hide glossary, plus policy/version text: Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions include Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-23T18:11:50.000Z thumbnail image

Stay in the know with updates to Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.